Sanuwave recently announced it appointed Morgan Frank as chief executive officer, effective immediately.
Frank has served 19 years as founder and principal of Manchester Management, Sanuwave’s largest outside shareholder, and has served as chair of the Sanuwave board of directors since August 2022.
Former CEO Kevin Richardson will remain on the board of directors of Sanuwave and continue in an active role as chief strategic officer.
“Having now been Sanuwave’s Chairman for nearly a year, I believe strongly in the Company and its mission to bring efficacious and cost-effective technology to the wound care market,” Frank said in a news release. “This is a very exciting time in our lifecycle as we seek to rapidly expand our manufacturing and explore and expand our commercial and strategic options. I would like to thank Kevin for his role in assembling this impressive product suite and setting the stage for future success.”
Prior to joining the company, Frank was a principal at Manchester Management. He has 29 years of U.S. public equity and capital markets experience with a focus on life sciences and technology, as well as corporate restarts and intellectual property salvage and monetization. He has provided long-term strategic planning, business development strategy and investor relations guidance to over 100 public companies.